euro adhoc: Curanum AG
Quarterly or Semiannual Financial Statements / CURANUM boosts EBIT by 92.8% in the first quarter

---------------------------------------------------------------------   Disclosure announcement transmitted by euro adhoc.   The issuer is responsible for the content of this announcement. ---------------------------------------------------------------------


In the first quarter of 2005, CURANUM AG, Munich, generated sales revenues of EUR 45.2 million (previous year: EUR 42.6 million), while total performance rose by 8.1 % to EUR 46.8 million (previous year: EUR 43.3 million). These developments were mainly attributable to higher capacity utilization, the consolidation of the Franziskushausgruppe, as well as recalculations of investment costs geared to increasing sales.

Earnings before interest, tax, depreciation and amortization (EBITDA) rose by 83.0 % to EUR 4.2 million (previous year: EUR 2.3 million) due to the virtually unchanged material costs over the same period last year and the personnel costs that increased in step with the sales revenues. In the first quarter, the EBITDA margin related to total performance stood at 9%. In spite of higher goodwill writedowns, earnings before interest and tax (EBIT) improved by 92.8% to EUR 3.2 million (previous year: EUR 1.7 million), while pre-tax earnings were up from EUR 1.4 million to EUR 3.1 million (+112,4%).

The financial result improved slightly to TEUR -157 (previous year: TEUR - 229), the taxes on earnings increased due to the considerably higher result from EUR 0.7 million to EUR 1.1 million. The Group surplus for the period amounted to EUR 1.9 million following on EUR 0.7 million in the previous year (+185.1%), while earnings per share (EPS) moved up from EUR 0.02 to EUR 0.06.

These results are based on the group financial statements of CURANUM AG prepared according to the German HGB reporting standards. The final quarterly report will be presented on May 17, 2005 and will be the first report to be drawn up according to the international IFRS standards.

Munich, May 9, 2005

The management board

end of announcement                                euro adhoc 09.05.2005 10:41:00

Further inquiry note: Bernd Rothe Tel.: +49 (0)89 242065-60 E-Mail:

Branche: Healthcare Providers
ISIN:      DE0005240709
WKN:        524070
Index:    Prime Standard, CDAX, Classic All Share, Prime All Share
Börsen:  Frankfurter Wertpapierbörse / regulated dealing
              Bayerische Börse / regulated dealing
              Berliner Wertpapierbörse / free trade
              Hamburger Wertpapierbörse / free trade
              Baden-Württembergische Wertpapierbörse / free trade
              Börse Düsseldorf / free trade
              Bremer Wertpapierbörse (BWB) / free trade

Weitere Meldungen: CURANUM AG

Das könnte Sie auch interessieren: